Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Monograph: Alkasar-18, 1-(beta-D-arabinofuranosyl)-4-octadecylamino-2(1H)-pyrimidin-one, N4-octadecyl-ara-C, NOAC
Schwendener R, Horber D, Ottiger C, Rentsch K, Fiebig H, Schott H. Monograph: Alkasar-18, 1-(beta-D-arabinofuranosyl)-4-octadecylamino-2(1H)-pyrimidin-one, N4-octadecyl-ara-C, NOAC. Drugs of the Future 1995; 20:11-15.
Jan 1, 1995Monograph: Alkasar-18, 1-(beta-D-arabinofuranosyl)-4-octadecylamino-2(1H)-pyrimidin-one, N4-octadecyl-ara-C, NOAC
Jan 1, 1995Drugs of the Future 1995; 20:11-15
Schwendener R., Horber Daniel, Ottiger C., Rentsch K.M., Fiebig H.H., Schott H.
Preclinical properties of N4-hexadecyl- and N4-octadecyl-1-beta-D-arabino-furanosylcytosine in liposomal preparations
Schwendener R, Horber D, Ottiger C, Schott H. Preclinical properties of N4-hexadecyl- and N4-octadecyl-1-beta-D-arabino-furanosylcytosine in liposomal preparations. J Liposome Res 1995; 5:27-47.
Jan 1, 1995Preclinical properties of N4-hexadecyl- and N4-octadecyl-1-beta-D-arabino-furanosylcytosine in liposomal preparations
Jan 1, 1995J Liposome Res 1995; 5:27-47
Schwendener R., Horber Daniel, Ottiger C., Schott H.
Phase II study of liposome-complexed mitoxantrone in patients with advanced breast cancer
Pestalozzi B, Vass A, Adam H, Horber D, Schwendener R, Sauter C. Phase II study of liposome-complexed mitoxantrone in patients with advanced breast cancer. Eur J Cancer 1995; 31A:1024.
Jan 1, 1995Phase II study of liposome-complexed mitoxantrone in patients with advanced breast cancer
Jan 1, 1995Eur J Cancer 1995; 31A:1024
Pestalozzi B., Vass A., Adam H., Horber Daniel, Schwendener R., Sauter C.
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research
Borner M, Cavalli F, Thürlimann B, Jungi W, Castiglione M, Harder F, Greiner R, Goldhirsch A, Bacchi M, Obrecht J. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol 1994; 12:2071-7.
Oct 1, 1994First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research
Oct 1, 1994J Clin Oncol 1994; 12:2071-7
Borner M, Cavalli F, Thürlimann Beat, Jungi W F, Castiglione M, Harder F, Greiner R, Goldhirsch A, Bacchi M, Obrecht J P
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]
Sinn H, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto H. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]. Geburtshilfe und Frauenheilkunde 1994; 54:552-8.
Oct 1, 1994[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]
Oct 1, 1994Geburtshilfe und Frauenheilkunde 1994; 54:552-8
Sinn H P, Schmid H, Junkermann H, Huober Jens, Leppien G, Kaufmann M, Bastert G, Otto H F
New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: Inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens
Schwendener R, Gowland P, Horber D, Zahner R, Schertler A, Schott H. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: Inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens. Antiviral Res 1994; 24:79-93.
May 1, 1994New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: Inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens
May 1, 1994Antiviral Res 1994; 24:79-93
Schwendener R., Gowland P., Horber Daniel, Zahner R., Schertler A., Schott H.
Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK)
Joss R, Bacchi M, Buser K, Kirchner V, Neuenschwander H, Orth B, Aapro M, Thürlimann B. Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 1994; 5:253-8.
Mar 1, 1994Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK)
Mar 1, 1994Ann Oncol 1994; 5:253-8
Joss R A, Bacchi M, Buser K, Kirchner V, Neuenschwander H, Orth B, Aapro M S, Thürlimann Beat
Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes
Driessen C, Hirv K, Rink L, Kirchner H. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine and cytokine research 1994; 13:15-20.
Feb 1, 1994Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes
Feb 1, 1994Lymphokine and cytokine research 1994; 13:15-20
Driessen Christoph, Hirv K, Rink L, Kirchner H
Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study
Thürlimann B, Morant R, Jungi W, Radziwill A. Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study. Support Care Cancer 1994; 2:61-5.
Jan 1, 1994Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study
Jan 1, 1994Support Care Cancer 1994; 2:61-5
Thürlimann Beat, Morant R, Jungi W F, Radziwill A
Present status and potential role of high-dose adjuvant chemotherapy in breast cancer with poor prognosis
Thürlimann B. Present status and potential role of high-dose adjuvant chemotherapy in breast cancer with poor prognosis. Arch Gynecol Obstet 1994; 255 Suppl 2:S379-80.
Jan 1, 1994Present status and potential role of high-dose adjuvant chemotherapy in breast cancer with poor prognosis
Jan 1, 1994Arch Gynecol Obstet 1994; 255 Suppl 2:S379-80
Thürlimann Beat
Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?
Thürlimann B. Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?. Ann Oncol 1994; 5 Suppl 7:S45-7.
Jan 1, 1994Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?
Jan 1, 1994Ann Oncol 1994; 5 Suppl 7:S45-7
Thürlimann Beat
Klinisch relevante Prognosefaktoren beim Mammakarzinom
Costa S, von Minkwitz G, Gremm B, Huober J, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel I, Kaufmann M, Bastert G. Klinisch relevante Prognosefaktoren beim Mammakarzinom. Klin Lab 1994; 40:1153-1166.
Jan 1, 1994Klinisch relevante Prognosefaktoren beim Mammakarzinom
Jan 1, 1994Klin Lab 1994; 40:1153-1166
Costa SD, von Minkwitz G, Gremm B, Huober Jens, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel IJ, Kaufmann M, Bastert G
Preclinical and clinical experience with liposome encapsulated mitoxantrone
Schwendener R, Horber D, Rentsch K, Haenseler E, Pestalozzi B, Sauter C. Preclinical and clinical experience with liposome encapsulated mitoxantrone. J Liposome Res 1994; 4:605-639.
Jan 1, 1994Preclinical and clinical experience with liposome encapsulated mitoxantrone
Jan 1, 1994J Liposome Res 1994; 4:605-639
Schwendener R., Horber Daniel, Rentsch K.M., Haenseler E., Pestalozzi B., Sauter C.
Synthesis, and some properties of amphiphilic dinucleoside phosphate derivatives of 3'-azido-2',3'-dideoxythymidine (AZT)
Schott H, Horber D, Zahner R, Gowland P, Schwendener R. Synthesis, and some properties of amphiphilic dinucleoside phosphate derivatives of 3'-azido-2',3'-dideoxythymidine (AZT). Antivir Chem Chemother 1994; 5:387-394.
Jan 1, 1994Synthesis, and some properties of amphiphilic dinucleoside phosphate derivatives of 3'-azido-2',3'-dideoxythymidine (AZT)
Jan 1, 1994Antivir Chem Chemother 1994; 5:387-394
Schott H., Horber Daniel, Zahner R., Gowland P., Schwendener R.
Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid
Laudiero L, Aloe L, Levi-Montalcini R, Buttinelli C, Schilter D, Gillessen Sommer S, Otten U. Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neuroscience letters 1992; 147:9-12.
Nov 23, 1992Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid
Nov 23, 1992Neuroscience letters 1992; 147:9-12
Laudiero L B, Aloe L, Levi-Montalcini R, Buttinelli C, Schilter D, Gillessen Sommer Silke, Otten U
Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial
Thürlimann B, Waldburger R, Senn H, Thiébaud D. Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial. Ann Oncol 1992; 3:619-23.
Sep 1, 1992Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial
Sep 1, 1992Ann Oncol 1992; 3:619-23
Thürlimann Beat, Waldburger R, Senn H J, Thiébaud D
Effective prevention of chemotherapy--induced phlebitis by low-dose heparin: a prospective randomised trial
Thürlimann B, Bachmann I. Effective prevention of chemotherapy--induced phlebitis by low-dose heparin: a prospective randomised trial. Ann Oncol 1992; 3:311-3.
Apr 1, 1992Effective prevention of chemotherapy--induced phlebitis by low-dose heparin: a prospective randomised trial
Apr 1, 1992Ann Oncol 1992; 3:311-3
Thürlimann Beat, Bachmann I
Psychotherapeutisch orientierte Musiktherapie im Latenzalter
Renz M. Psychotherapeutisch orientierte Musiktherapie im Latenzalter. Musiktherapie 1992; 20:11-29.
Jan 1, 1992Psychotherapeutisch orientierte Musiktherapie im Latenzalter
Jan 1, 1992Musiktherapie 1992; 20:11-29
Renz Monika
[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
Morant R, Thürlimann B, Jungi W, Schmid L, Holdener E, Schmid U, Senn H. [Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]. Schweiz Med Wochenschr 1991; 121:344-6.
Mar 9, 1991[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
Mar 9, 1991Schweiz Med Wochenschr 1991; 121:344-6
Morant R, Thürlimann Beat, Jungi W F, Schmid L, Holdener E, Schmid U, Senn H J
Metabolism of debrisoquine and susceptibility to breast cancer
Huober J, Bertram B, Petru E, Kaufmann M, Schmähl D. Metabolism of debrisoquine and susceptibility to breast cancer. Breast cancer research and treatment 1991; 18:43-8.
Mar 1, 1991Metabolism of debrisoquine and susceptibility to breast cancer
Mar 1, 1991Breast cancer research and treatment 1991; 18:43-8
Huober Jens, Bertram B, Petru E, Kaufmann M, Schmähl D